Tribavirin may be helpful

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6986.1065a (Published 22 April 1995) Cite this as: BMJ 1995;310:1065
  1. Nicholas Hallam,
  2. Trevor Edmunds
  1. Consultant virologist Regional Virus Laboratory, City Hospital, Royal Infirmary of Edinburgh NHS Trust, Edinburgh EH10 5SB
  2. Consultant paediatrician Royal Hospital for Sick Children, Edinburgh Sick Children's NHS Trust, Edinburgh EH9 1LF

    EDITOR,—David Isaacs makes no mention of tribavirin in the management of bronchiolitis.1 Despite its limited efficacy, possible toxicity, and expense (three 6 g phials cost pounds sterling585) the synthetic nucleoside tribavirin is the only specific antiviral agent licensed for treatment of respiratory syncytial virus infection (the main cause of bronchiolitis) and merits further …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription